0

GW843682X

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP660868917-A
CAS660868-91-7
Structure
MDL NumberMFCD09971143
Molecular Weight477.46
InChI KeyJSKUWFIZUALZLX-UHFFFAOYSA-N
Description≥98% (HPLC), solid
SolubilityDMSO: >10 mg/mL
Assay≥98% (HPLC)
Coloroff-white
Formsolid
Size1MG, 5MG
Storage Conditions2-8°C
1

An In-Vitro Evaluation of the Polo-Like Kinase Inhibitor GW843682X Against Paediatric Malignancies

Kristina Spaniol, Joachim Boos, Claudia Lanvers-Kaminsky

Anticancer Drugs. 2011 Jul;22(6):531-42.

PMID: 21637161

1

Polo-like Kinase 1 (PLK1) Is Involved in Toll-Like Receptor (TLR)-mediated TNF-α Production in Monocytic THP-1 Cells

Jinyue Hu, Guihua Wang, Xueting Liu, Lina Zhou, Manli Jiang, Li Yang

PLoS One. 2013 Oct 18;8(10):e78832.

PMID: 24205328

1

Polo-like Kinase 1 Inhibition Causes Decreased Proliferation by Cell Cycle Arrest, Leading to Cell Death in Glioblastoma

J A Pezuk, M S Brassesco, A G Morales, J C de Oliveira, R G de Paula Queiroz, H R Machado, C G Carlotti Jr, L Neder, C A Scrideli, L G Tone

Cancer Gene Ther. 2013 Sep;20(9):499-506.

PMID: 23887645

1

Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells

Julia Alejandra Pezuk, Maria Sol Brassesco, Priscila Maria Manzini Ramos, Carlos Alberto Scrideli, Luiz Gonzaga Tone

Anticancer Agents Med Chem. 2017;17(9):1278-1291.

PMID: 28270075

1

The Cytotoxic Effect of GW843682X on Nasopharyngeal Carcinoma

Qinyong Hu, Yuxin Chu, Weiguo Hu, Min Peng, Qibin Song

Anticancer Agents Med Chem. 2016;16(12):1640-1645.

PMID: 27198987

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode